Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14201 - 14225 of 14927 in total
Experimental
AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued.
Investigational
Matched Description: … Phase I trials were initiated January 2003, and were ongoing as of February 2004. …
Experimental
Illicit
Experimental
Experimental
Experimental
GW-3965 is a liver X receptor ligand.
Experimental
Experimental
Displaying drugs 14201 - 14225 of 14927 in total